Identification and verification of FN1, P4HA1 and CREBBP as potential biomarkers in human atrial fibrillation

Miao Zhu1, Tao Yan1, Shijie Zhu1

  • 1Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.

Insights

Atrial fibrillation (AF) mechanisms were explored using bioinformatics. Three key genes (FN1, P4HA1, CREBBP) were identified as potential biomarkers for AF, showing elevated expression in patients.

Area of Science:

  • Cardiology
  • Bioinformatics
  • Molecular Biology

Background:

  • Atrial fibrillation (AF) is a prevalent arrhythmia linked to cardiac complications.
  • The underlying mechanisms driving AF progression remain incompletely understood.
  • Identifying novel biomarkers and molecular pathways is crucial for AF management.

Purpose of the Study:

  • To investigate potential biomarkers and elucidate the molecular mechanisms associated with atrial fibrillation (AF).
  • To identify key genes and pathways involved in the pathogenesis of AF using a bioinformatics approach.

Main Methods:

  • Differential gene expression analysis of AF versus normal sinus rhythm (SR) samples using the "limma" R package.
  • Weighted gene co-expression network analysis (WGCNA) to identify gene modules and functional relationships.
  • Enrichment analyses (GO, KEGG) and protein-protein interaction network construction to pinpoint hub genes.

Main Results:

  • 2,589 differentially expressed genes (DEGs) were identified and clustered into 10 modules.
  • Enrichment analysis highlighted pathways related to extracellular matrix organization and cell adhesion.
  • Three hub genes (FN1, P4HA1, CREBBP) were identified with significantly elevated mRNA expression in AF patients.

Conclusions:

  • FN1, P4HA1, and CREBBP are strongly implicated in AF pathogenesis.
  • These genes exhibit elevated expression and central roles in molecular networks within AF patients.
  • The identified hub genes represent promising candidates for novel AF biomarkers and therapeutic targets.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
208
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
42